SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-132572
Filing Date
2021-04-27
Accepted
2021-04-27 07:05:29
Documents
4
Period of Report
2021-04-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d147711d8k.htm 8-K 20359
2 EX-10.1 d147711dex101.htm EX-10.1 57305
3 EX-99.1 d147711dex991.htm EX-99.1 11711
4 GRAPHIC g147711g0427011732469.jpg GRAPHIC 6299
  Complete submission text file 0001193125-21-132572.txt   99442
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38459 | Film No.: 21855845
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences